Article
Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis.
Nature genetics - 1 Mar 2013
Twigg Stephen R F, Vorgia Elena, McGowan Simon J, Peraki Ioanna, Fenwick Aimée L, Sharma Vikram P, Allegra Maryline, Zaragkoulias Andreas, Sadighi Akha Elham, Knight Samantha J L, Lord Helen, Lester Tracy, Izatt Louise, Lampe Anne K, Mohammed Shehla N, Stewart Fiona J, Verloes Alain, Wilson Louise C, Healy Chris, Sharpe Paul T, Hammond Peter, Hughes Jim, Taylor Stephen, Johnson David, Wall Steven A, Mavrothalassitis George, Wilkie Andrew O M
Abstract excerpt
The extracellular signal-related kinases 1 and 2 (ERK1/2) are key proteins mediating mitogen-activated protein kinase signaling downstream of RAS: phosphorylation of ERK1/2 leads to nuclear uptake and modulation of multiple targets. Here, we show that reduced dosage of ERF, which encodes an inhibitory ETS transcription factor directly bound by ERK1/2 (refs. 2,3,4,5,6,7), causes complex craniosynostosis (premature...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
